Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice
Citation
Thompson , D , Mahmood , S , Morrice , N , Kamli-Salino , S , Dekeryte , R , Hoffmann , P , Doherty , M K , Whitfield , P D , Delibegović , M & Mody , N 2023 , ' Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice ' , Scientific Reports , vol. 13 , 3937 . https://doi.org/10.1101/2022.07.22.500933 , https://doi.org/10.1038/s41598-023-30759-w